MXPA03004303A - DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR. - Google Patents
DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR.Info
- Publication number
- MXPA03004303A MXPA03004303A MXPA03004303A MXPA03004303A MXPA03004303A MX PA03004303 A MXPA03004303 A MX PA03004303A MX PA03004303 A MXPA03004303 A MX PA03004303A MX PA03004303 A MXPA03004303 A MX PA03004303A MX PA03004303 A MXPA03004303 A MX PA03004303A
- Authority
- MX
- Mexico
- Prior art keywords
- acetic acid
- aminothien
- aminofuran
- pain
- substituted derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10059864A DE10059864A1 (de) | 2000-11-30 | 2000-11-30 | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
| PCT/EP2001/013910 WO2002044171A1 (de) | 2000-11-30 | 2001-11-28 | Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03004303A true MXPA03004303A (es) | 2003-08-19 |
Family
ID=7665508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03004303A MXPA03004303A (es) | 2000-11-30 | 2001-11-28 | DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6797712B2 (es) |
| EP (1) | EP1341786B9 (es) |
| JP (1) | JP4340063B2 (es) |
| KR (1) | KR20030055334A (es) |
| CN (1) | CN1326854C (es) |
| AR (1) | AR035658A1 (es) |
| AT (1) | ATE418552T1 (es) |
| AU (2) | AU2073502A (es) |
| BR (1) | BR0115883A (es) |
| CA (1) | CA2430280A1 (es) |
| CY (1) | CY1108871T1 (es) |
| CZ (1) | CZ20031509A3 (es) |
| DE (2) | DE10059864A1 (es) |
| DK (1) | DK1341786T3 (es) |
| EC (1) | ECSDI034631S (es) |
| ES (1) | ES2320198T3 (es) |
| HK (1) | HK1059080A1 (es) |
| HU (1) | HUP0303041A3 (es) |
| IL (2) | IL156139A0 (es) |
| MX (1) | MXPA03004303A (es) |
| NO (1) | NO20032340L (es) |
| NZ (1) | NZ526554A (es) |
| PE (1) | PE20020599A1 (es) |
| PL (1) | PL362978A1 (es) |
| PT (1) | PT1341786E (es) |
| RU (1) | RU2003117703A (es) |
| SI (1) | SI1341786T1 (es) |
| SK (1) | SK5942003A3 (es) |
| WO (1) | WO2002044171A1 (es) |
| ZA (1) | ZA200305009B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794506B2 (en) * | 2000-07-21 | 2004-09-21 | Elan Pharmaceuticals, Inc. | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| DE10125145A1 (de) | 2001-05-22 | 2002-11-28 | Gruenenthal Gmbh | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
| GB0302094D0 (en) * | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| DE10306203A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US10144736B2 (en) * | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
| US9259426B2 (en) | 2006-07-20 | 2016-02-16 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| LT3097102T (lt) | 2015-03-04 | 2018-01-25 | Gilead Sciences, Inc. | 4,6-diamino-pirido[3,2-d]pirimidino junginiai, moduliuojantys į toll panašius receptorius |
| US10370342B2 (en) | 2016-09-02 | 2019-08-06 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
| US10640499B2 (en) | 2016-09-02 | 2020-05-05 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
| TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TW202212339A (zh) | 2019-04-17 | 2022-04-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
| CN115382297B (zh) * | 2022-04-12 | 2023-10-31 | 江阴市华思诚无纺布有限公司 | 熔体直纺双组分pet纺粘液体过滤材料及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3718397A (en) * | 1996-06-28 | 1998-01-21 | University Of Southern California | Method for the synthesis of amines and amino acids with organoboron derivatives |
| DE19907385A1 (de) * | 1999-02-20 | 2000-08-24 | Boehringer Ingelheim Pharma | Neue substituierte 3-Phenoxy- und 3-Phenylalkyloxy-2-phenyl-propylamine |
| US6441237B1 (en) | 1999-02-20 | 2002-08-27 | Boehringer Ingelheim Pharma Kg | Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
-
2000
- 2000-11-30 DE DE10059864A patent/DE10059864A1/de not_active Ceased
-
2001
- 2001-11-26 AR ARP010105486A patent/AR035658A1/es not_active Application Discontinuation
- 2001-11-28 CN CNB018197876A patent/CN1326854C/zh not_active Expired - Fee Related
- 2001-11-28 DK DK01998547T patent/DK1341786T3/da active
- 2001-11-28 SI SI200130905T patent/SI1341786T1/sl unknown
- 2001-11-28 KR KR10-2003-7007315A patent/KR20030055334A/ko not_active Application Discontinuation
- 2001-11-28 DE DE50114605T patent/DE50114605D1/de not_active Expired - Lifetime
- 2001-11-28 NZ NZ526554A patent/NZ526554A/en unknown
- 2001-11-28 BR BR0115883-0A patent/BR0115883A/pt not_active IP Right Cessation
- 2001-11-28 ES ES01998547T patent/ES2320198T3/es not_active Expired - Lifetime
- 2001-11-28 IL IL15613901A patent/IL156139A0/xx active IP Right Grant
- 2001-11-28 PL PL01362978A patent/PL362978A1/xx not_active Application Discontinuation
- 2001-11-28 MX MXPA03004303A patent/MXPA03004303A/es active IP Right Grant
- 2001-11-28 CA CA002430280A patent/CA2430280A1/en not_active Abandoned
- 2001-11-28 PT PT01998547T patent/PT1341786E/pt unknown
- 2001-11-28 CZ CZ20031509A patent/CZ20031509A3/cs unknown
- 2001-11-28 JP JP2002546541A patent/JP4340063B2/ja not_active Expired - Fee Related
- 2001-11-28 HU HU0303041A patent/HUP0303041A3/hu unknown
- 2001-11-28 WO PCT/EP2001/013910 patent/WO2002044171A1/de active IP Right Grant
- 2001-11-28 AT AT01998547T patent/ATE418552T1/de active
- 2001-11-28 SK SK594-2003A patent/SK5942003A3/sk not_active Application Discontinuation
- 2001-11-28 AU AU2073502A patent/AU2073502A/xx active Pending
- 2001-11-28 RU RU2003117703/04A patent/RU2003117703A/ru not_active Application Discontinuation
- 2001-11-28 AU AU2002220735A patent/AU2002220735B2/en not_active Ceased
- 2001-11-28 EP EP01998547A patent/EP1341786B9/de not_active Expired - Lifetime
- 2001-11-29 PE PE2001001195A patent/PE20020599A1/es not_active Application Discontinuation
-
2003
- 2003-05-23 NO NO20032340A patent/NO20032340L/no not_active Application Discontinuation
- 2003-05-27 IL IL156139A patent/IL156139A/en not_active IP Right Cessation
- 2003-05-29 EC EC2003004631F patent/ECSDI034631S/es unknown
- 2003-05-30 US US10/448,323 patent/US6797712B2/en not_active Expired - Fee Related
- 2003-06-26 ZA ZA200305009A patent/ZA200305009B/en unknown
-
2004
- 2004-03-09 HK HK04101704.1A patent/HK1059080A1/xx not_active IP Right Cessation
-
2009
- 2009-03-12 CY CY20091100279T patent/CY1108871T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| HUP0302719A3 (en) | Substituted amine derivatives and their use for the treatment of angiogenesis | |
| AU6048201A (en) | Quinazoline derivatives for the treatment of tumours | |
| IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| IS6560A (is) | Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni | |
| NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| MXPA03004303A (es) | DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR. | |
| AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
| HK1041827A1 (en) | Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame. | |
| HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
| IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
| HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
| GB0026923D0 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin | |
| GB9904252D0 (en) | Composition for the treatment of pain | |
| HUP0300313A3 (en) | Compound, pharmaceutical composition containing it and its use for the treatment of pain | |
| HU9900123D0 (en) | 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof | |
| HK1042039A1 (en) | Use of phanquinone for the treatment or preventionof memory impairment. | |
| IL143795A0 (en) | Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections | |
| GB9926985D0 (en) | Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases | |
| SI1282616T1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain | |
| SI1472221T1 (sl) | Substituirani indoli, postopek za pripravo in njihova uporaba za odpravljanje bolecin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |